Evaluating the effects of high amylase levels after pancreas surgery on recovery and safety

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to prospectively evaluate the incidence of postoperative hyperamylasemia (POH) in patients who have undergone pancreatectomy and its clinical implications on postoperative outcomes. By analyzing biochemical changes and correlating them with other laboratory parameters, the study seeks to enhance the understanding of postpancreatectomy acute pancreatitis (PPAP) and improve its classification according to international standards. The findings could lead to better management strategies for complications arising after pancreatic surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All patients undergoing pancreatic resection for malignant and benign disease with or without pancreatic anastomosis
* Patients aged 18-85 years
* Willingness to participate as demonstrated by giving a written informed consent.

Exclusion Criteria:

* Necrosectomy (endoscopic or open) for primary acute pancreatitis or within laparotomy
* Age less than 18 years
* Surgical drainage procedures without pancreatic resection (cystojejunostomy for pancreatic pseudocysts)
* One-stage total pancreatectomy
* Missing written consent

Where it's running

• University Hospital Dresden, Dept. Visceral, Thoracic and Vascular Surgery
  Dresden, Germany Recruiting

Study contacts

• Principal investigator: Marius Distler, Prof. Dr. — University Hospital Dresden
• Study coordinator: Olga Radulova-Mauersberger, Dr. med.
• Email: studienzentrum-vtg@ukdd.de
• Phone: +49 351 458-0

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ice water plus NSAIDs to prevent post-ERCP pancreatitis

  This study tests whether adding ice-cold water irrigation to the standard NSAID prevention can further reduce post-ERCP pancreatitis in adults.

  Recruiting Instituto do Cancer do Estado de São Paulo · São Paulo, São Paulo · NCT07738094

• Pancreatic Surgery and New Diabetes Risk in Adults without Diabetes

  This study tests whether removing part or all of the pancreas during surgery affects blood sugar control and metabolism in adults who did not have diabetes before the operation.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT07608055

• PancreasPlus app for monitoring recovery, symptoms, and education after pancreatic cancer treatment

  This project will test whether the PancreasPlus app helps adults with pancreatic cancer and their caregivers monitor symptoms, get timely information, and communicate with their healthcare team.

  Recruiting Casa di Cura Dott. Pederzoli · Pavia, Pavia and 1 other locations · NCT07532590

• Hybrid Closed-Loop Insulin Delivery After Pancreatectomy

  This study tests whether a commercially available monohormonal hybrid closed-loop insulin delivery system can help adults who developed diabetes after pancreatectomy better manage blood sugar.

  Recruiting Centre Hospitalier Sud Francilien · Corbeil-Essonnes, France and 1 other locations · NCT07430293

• Efferon LPS hemoadsorption with hemofiltration for acute pancreatitis

  This trial will test whether adding Efferon LPS hemoadsorption to hemofiltration/hemodiafiltration helps patients with moderate-to-severe acute pancreatitis reduce organ dysfunction.

  Recruiting at 8 sites Efferon JSC · Kazan' and 7 other locations · NCT07267169

• Indometacin with or without extra IV fluids to prevent pancreatitis after pancreatic stone shock-wave treatment

  This study will test whether giving aggressive intravenous fluids in addition to rectal indometacin reduces the chance of pancreatitis after ESWL for pancreatic stones.

  Recruiting at 8 sites Changhai Hospital · Baotou and 9 other locations · NCT07202559

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.